The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NIIMBL eXperience, the largest cohort since the Program’s launch in 2019. Students will participate in one of five NIIMBL eXperience programs hosted by Albany...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed...
The Advanced Manufacturing National Program Office held its annual Manufacturing USA Network Meeting on May 25 in Washington, DC. There were over 100 participants with representatives from each of the institutes and funding agencies attending nine unique sessions throughout the day.
Dr. Monica Gorman, Special Assistant to the President for...
The National Institute of Standards and Technology (NIST) has issued a Notice of Funding Opportunity for Manufacturing USA Workforce, Education and Vibrant Ecosystems (WEAVE) public serve awards to the 17 Manufacturing USA institutes for proposals in the following topic areas:
Partnerships amongst two or more institutes to build vibrant and...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project activities through the Institute’s Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro potency assays for vaccines being produced by mRNA and/or viral...
